{"id":"https://openalex.org/W1529517822","doi":"https://doi.org/10.1111/j.1610-0387.2010.07568.x","title":"Treatment and side effect management of CTLA\u20104 antibody therapy in metastatic melanoma","display_name":"Treatment and side effect management of CTLA\u20104 antibody therapy in metastatic melanoma","alternate_titles":[],"publication_year":2010,"publication_date":"2010-11-17","ids":{"openalex":"https://openalex.org/W1529517822","doi":"https://doi.org/10.1111/j.1610-0387.2010.07568.x","mag":"1529517822","pmid":"https://pubmed.ncbi.nlm.nih.gov/21083648"},"language":"en","primary_location":{"id":"doi:10.1111/j.1610-0387.2010.07568.x","doi":"https://doi.org/10.1111/j.1610-0387.2010.07568.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1610-0387.2010.07568.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210169996","display_name":"JDDG Journal der Deutschen Dermatologischen Gesellschaft","issn_l":"1610-0379","issn":["1610-0379","1610-0387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1529517822"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031315234","display_name":"Katharina Charlotte K\u00e4hler","orcid":"https://orcid.org/0000-0001-9953-0893","observed_orcids":["https://orcid.org/0000-0001-9953-0893"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Katharina C. K\u00e4hler","raw_affiliation_strings":["Department of Dermatology, Venerology and Allergology, University of Schleswig-Holstein Hospital, Campus Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venerology and Allergology, University of Schleswig-Holstein Hospital, Campus Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044736874","display_name":"Axel Hauschild","orcid":"https://orcid.org/0000-0002-1212-9587","observed_orcids":["https://orcid.org/0000-0002-1212-9587"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Axel Hauschild","raw_affiliation_strings":["Department of Dermatology, Venerology and Allergology, University of Schleswig-Holstein Hospital, Campus Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Venerology and Allergology, University of Schleswig-Holstein Hospital, Campus Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031315234"],"corresponding_institution_ids":["https://openalex.org/I4210112713"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":5.2503,"has_fulltext":false,"cited_by_count":113,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96387003,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"9","issue":"4","first_page":"277","last_page":"286"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ctla-4-antibody","display_name":"CTLA-4 antibody","score":0.8999999761581421},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8920000195503235},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tremelimumab","display_name":"tremelimumab","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7680000066757202},{"id":"https://openalex.org/keywords/autoimmune-adverse-events","display_name":"autoimmune adverse events","score":0.7720000147819519},{"id":"https://openalex.org/keywords/autoimmune-colitis","display_name":"autoimmune colitis","score":0.8870000243186951},{"id":"https://openalex.org/keywords/hypophysitis","display_name":"hypophysitis","score":0.8939999938011169},{"id":"https://openalex.org/keywords/hepatitis","display_name":"hepatitis","score":0.6899999976158142},{"id":"https://openalex.org/keywords/iridocyclitis","display_name":"iridocyclitis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.9399999976158142},{"id":"https://openalex.org/keywords/b7-family","display_name":"B7 family","score":0.42800000309944153},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.7910000085830688},{"id":"https://openalex.org/keywords/side-effect-management","display_name":"side effect management","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9009070992469788},{"id":"https://openalex.org/C2778650287","wikidata":"https://www.wikidata.org/wiki/Q7838098","display_name":"Tremelimumab","level":5,"score":0.8588690757751465},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8039557933807373},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6668261289596558},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.6530203819274902},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5083462595939636},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4772900640964508},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4313734173774719},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.42368483543395996},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4111831486225128},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3560131788253784},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.23829182982444763},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08394515514373779},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018448","descriptor_name":"Models, Immunological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1610-0387.2010.07568.x","doi":"https://doi.org/10.1111/j.1610-0387.2010.07568.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1610-0387.2010.07568.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210169996","display_name":"JDDG Journal der Deutschen Dermatologischen Gesellschaft","issn_l":"1610-0379","issn":["1610-0379","1610-0387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft","raw_type":"journal-article"},{"id":"pmid:21083648","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21083648","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1845726423","https://openalex.org/W1967589931","https://openalex.org/W1982889687","https://openalex.org/W1987234856","https://openalex.org/W2006091295","https://openalex.org/W2006156545","https://openalex.org/W2017030654","https://openalex.org/W2095826876","https://openalex.org/W2097995306","https://openalex.org/W2107150019","https://openalex.org/W2109465910","https://openalex.org/W2119198740","https://openalex.org/W2143467222","https://openalex.org/W2145308813","https://openalex.org/W2149748445","https://openalex.org/W2151507811","https://openalex.org/W2164918836","https://openalex.org/W2203317209","https://openalex.org/W2280151081","https://openalex.org/W2285888003","https://openalex.org/W2307268359"],"related_works":["https://openalex.org/W2081521066","https://openalex.org/W2467925070","https://openalex.org/W2062109360","https://openalex.org/W2127505226","https://openalex.org/W3030240040","https://openalex.org/W2053551865","https://openalex.org/W1977991856","https://openalex.org/W2112069616","https://openalex.org/W1966926280","https://openalex.org/W2280856093"],"abstract_inverted_index":{"Immune-modifying":[0],"monoclonal":[1],"antibodies":[2,53,63,98],"may":[3,120],"induce":[4,54],"or":[5,170],"enhance":[6],"the":[7,41,61,78,87,101,107,180,191,211,222,234],"natural":[8],"immune":[9,25],"response":[10,26],"against":[11],"tumor":[12],"cells.":[13,50],"The":[14,33,133],"complex":[15],"interaction":[16],"between":[17],"antigen-presenting":[18],"cells":[19],"and":[20,65,91,131,159,185,228],"T":[21,49],"lymphocytes":[22],"as":[23,142],"an":[24,55,143,171,216],"is":[27,85,147],"strongly":[28],"affected":[29],"by":[30,150],"anti-CD152":[31],"(CTLA-4)-antibodies.":[32],"cytotoxic":[34],"T-lymphocyte":[35],"(CTLA-4)":[36],"receptor":[37],"binds":[38],"molecules":[39,105],"of":[40,48,109,173,193,213,237],"B7-family":[42],"which":[43,146],"leads":[44],"to":[45,93,95,100,153,189,203],"a":[46,151],"suppression":[47],"Specific":[51],"CTLA-4":[52,62,97,115],"unrestrained":[56],"T-cell":[57],"activation.":[58],"Treatment":[59],"with":[60,114,127,206,221],"ipilimumab":[64,84],"tremelimumab":[66],"has":[67],"been":[68,177],"investigated":[69],"in":[70,86,179],"metastatic":[71,226],"melanoma":[72],"only":[73],"within":[74],"clinical":[75,219],"trials.":[76],"Currently,":[77],"critical":[79],"phase":[80],"III":[81],"trial":[82],"on":[83,218],"final":[88],"analysis":[89],"process":[90],"expected":[92],"lead":[94],"approval.":[96],"belong":[99],"most":[102,134],"promising":[103],"new":[104,239],"for":[106,195,225,232],"treatment":[108,113,130,186,207],"advanced":[110],"melanoma.":[111],"During":[112],"antibodies,":[116],"distinct":[117],"adverse":[118],"events":[119],"occur.":[121],"Treating":[122],"physicians":[123],"must":[124],"be":[125],"familiar":[126],"their":[128],"appropriate":[129],"prophylaxis.":[132],"frequently":[135],"observed":[136],"side":[137,164,199,235],"effects":[138,165,200,236],"are":[139,187,201],"diseases":[140],"such":[141],"autoimmune":[144],"colitis":[145],"typically":[148],"characterized":[149],"mild":[152],"moderate,":[154],"but":[155],"occasionally":[156],"also":[157],"severe":[158],"persistent":[160],"diarrhea.":[161],"Other":[162],"autoimmune-mediated":[163],"like":[166],"hypophysitis,":[167],"hepatitis,":[168],"iridocyclitis":[169],"exacerbation":[172],"lupus":[174],"nephritis":[175],"have":[176],"reported":[178,202],"literature.":[181],"Their":[182],"early":[183],"recognition":[184],"mandatory":[188],"reduce":[190],"risk":[192],"sequelae":[194],"CTLA-4-antibod-treated":[196],"patients.":[197],"Autoimmune-mediated":[198],"correlate":[204],"positively":[205],"response.":[208],"We":[209],"review":[210],"mechanisms":[212],"action,":[214],"provide":[215],"update":[217],"trials":[220],"two":[223],"CTLA-4-antibodies":[224],"melanoma,":[227],"present":[229],"detailed":[230],"recommendations":[231],"managing":[233],"these":[238],"agents.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1529517822","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":19},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
